Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
Di Sabatino A, Battista N, Biancheri P, Rapino C, Rovedatti L, Astarita G, Vanoli A, Dainese E, Guerci M, Piomelli D, Pender SL, MacDonald TT, Maccarrone M, Corazza GR. Di Sabatino A, et al. Among authors: macdonald tt. Mucosal Immunol. 2011 Sep;4(5):574-83. doi: 10.1038/mi.2011.18. Epub 2011 Apr 6. Mucosal Immunol. 2011. PMID: 21471961 Free article.
New pathogenic paradigms in inflammatory bowel disease.
Di Sabatino A, Biancheri P, Rovedatti L, MacDonald TT, Corazza GR. Di Sabatino A, et al. Among authors: macdonald tt. Inflamm Bowel Dis. 2012 Feb;18(2):368-71. doi: 10.1002/ibd.21735. Epub 2011 Apr 27. Inflamm Bowel Dis. 2012. PMID: 21538717 Review.
Proteases and the gut barrier.
Biancheri P, Di Sabatino A, Corazza GR, MacDonald TT. Biancheri P, et al. Among authors: macdonald tt. Cell Tissue Res. 2013 Feb;351(2):269-80. doi: 10.1007/s00441-012-1390-z. Epub 2012 Mar 20. Cell Tissue Res. 2013. PMID: 22427120 Review.
Absence of a role for interleukin-13 in inflammatory bowel disease.
Biancheri P, Di Sabatino A, Ammoscato F, Facciotti F, Caprioli F, Curciarello R, Hoque SS, Ghanbari A, Joe-Njoku I, Giuffrida P, Rovedatti L, Geginat J, Corazza GR, MacDonald TT. Biancheri P, et al. Among authors: macdonald tt. Eur J Immunol. 2014 Feb;44(2):370-85. doi: 10.1002/eji.201343524. Eur J Immunol. 2014. PMID: 24338958 Free article.
Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
Di Sabatino A, Rovedatti L, Kaur R, Spencer JP, Brown JT, Morisset VD, Biancheri P, Leakey NA, Wilde JI, Scott L, Corazza GR, Lee K, Sengupta N, Knowles CH, Gunthorpe MJ, McLean PG, MacDonald TT, Kruidenier L. Di Sabatino A, et al. Among authors: macdonald tt. J Immunol. 2009 Sep 1;183(5):3454-62. doi: 10.4049/jimmunol.0802887. Epub 2009 Jul 31. J Immunol. 2009. PMID: 19648266
Involvement of CD40-CD40 ligand in uncomplicated and refractory celiac disease.
Di Sabatino A, Rovedatti L, Vetrano S, Vidali F, Biancheri P, Rescigno M, Danese S, Macdonald TT, Corazza GR. Di Sabatino A, et al. Among authors: macdonald tt. Am J Gastroenterol. 2011 Mar;106(3):519-27. doi: 10.1038/ajg.2010.450. Epub 2010 Dec 7. Am J Gastroenterol. 2011. PMID: 21139574
Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.
Biancheri P, Brezski RJ, Di Sabatino A, Greenplate AR, Soring KL, Corazza GR, Kok KB, Rovedatti L, Vossenkämper A, Ahmad N, Snoek SA, Vermeire S, Rutgeerts P, Jordan RE, MacDonald TT. Biancheri P, et al. Among authors: macdonald tt. Gastroenterology. 2015 Nov;149(6):1564-1574.e3. doi: 10.1053/j.gastro.2015.07.002. Epub 2015 Jul 11. Gastroenterology. 2015. PMID: 26170138 Free article.
365 results